Reference
Yamamoto M, et al. Outcomes of an Independent Clinical Study to Compare Branded and Generic Formulations of Sustained-Release Oxycodone. Gan to Kagaku Ryoho 44: 261-264, No. 3, Mar 2017 [Japanese; summarised from a translation] - Japan
Rights and permissions
About this article
Cite this article
Afatinib/amrubicin/oxycodone. Reactions Weekly 1664, 25 (2017). https://doi.org/10.1007/s40278-017-34305-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-017-34305-7